You are here

Takeda

Takeda's maribavir clears cytomegalovirus infections in phase 3

Fierce Biotech

Fri, 02/12/21 - 11:02 am

clinical trials

Ensoma debuts with $70M, Takeda deal to pursue off-the-shelf genomic medicines

Fierce Biotech

Thu, 02/11/21 - 10:37 am

genomic medicine

Takeda GI veteran Parikh takes charge at 'molecular machines' biotech MOMA Therapeutics

Fierce Biotech

Mon, 02/1/21 - 10:30 am

MOMA Therapeutics

Takeda earns win for its TKI inhibitor in tiny lung cancer group — but GI side effects could be an early red flag

Endpoints

Thu, 01/28/21 - 10:41 am

non-small cell lung cancer

Takeda’s gene editing partner is snapped up for $250M cash as sector continues to heat up

Endpoints

Tue, 12/15/20 - 08:22 pm

ASH: Takeda pads case for new leukemia use with 5-year survival data

Fierce Pharma

Tue, 12/8/20 - 12:11 am

BioCryst takes on Takeda, CSL with FDA approval for Orladeyo, the first pill to prevent HAE attacks

Fierce Pharma

Sat, 12/5/20 - 11:26 pm

Takeda's maribavir hits phase 3 goal as pharma looks forward to regulatory talks

Fierce Biotech

Fri, 12/4/20 - 11:00 am

clinical trials

Amgen, Takeda, UCB enroll first patient in Covid-19 global platform study

Pharmaceutical Business Review

Wed, 12/2/20 - 10:24 am

clinical trials

COVID R&D Alliance

Pharvaris lands another $80M as it looks to tackle Takeda and CSL with an oral approach for HAE

Endpoints

Wed, 11/18/20 - 11:07 pm

Takeda to partner on patient-centric data with Seqster

Pharmaforum

Thu, 10/29/20 - 10:50 pm

Takeda Joins Forces with Accenture, AWS to Transform to Cloud-Based Company

BioSpace

Wed, 10/14/20 - 05:33 pm

Amazon Web Services

cloud platforms

Key trial test begins for plasma-based COVID-19 therapy from Takeda, CSL

BioPharma Dive

Sat, 10/10/20 - 11:27 pm

clinical trials

Takeda drops $300M cash to kick off $1B RNAi alliance with Arrowhead, shooting for first-in-class rare disease drug

Endpoints

Thu, 10/8/20 - 10:59 am

Arrowhead Pharmaceuticals

Fourth-quarter events to watch for big pharma

EP Vantage

Mon, 09/28/20 - 10:34 pm

clinical trials

Gilead Sciences

Alzheimer's disease

Bristol-Myers Squibb

Takeda opens cell therapy manufacturing facility — tucked right in its Boston R&D hub

Endpoints

Tue, 09/15/20 - 10:50 am

drug manufacturing

Takeda to sell another non-core portfolio for $260 million to Cheplapharm

Pharmafile

Tue, 09/8/20 - 10:33 pm

Moderna in Talks to Sell 40 Million Coronavirus Vaccine Doses to Japan

Motley Fool

Sat, 08/29/20 - 11:57 pm

Moderna Therapeutics

Ovid gets quick raise off PhII seizure results. Can the results hold up against GW?

Endpoints

Tue, 08/25/20 - 09:57 pm

Ovid Therapeutics

clinical trials

Dravet syndrome

Lennox-Gastaut Syndrome

Takeda inks up to $500M collaboration with extra-cellular matrix biotech for NASH

Endpoints

Tue, 08/25/20 - 09:52 pm

drug development

Pages